atrial fibrillation
A take-home wearable ECG could be key in detecting undiagnosed atrial fibrillation, according to a new study published in JAMA this morning.
Smartwatches were able to detect atrial fibrillation when paired with a deep neural network, according to a study published today in JAMA.
A smartphone app developed the University of Turku, Finland, detected Turku University Hospital patients’ atrial fibrillation with 96 percent accuracy, without the need for additional phone attachments, according to a study recently published in the journal Circulation.
Patients at increased risk for atrial fibrillation wearing iRhythm’s Zio patch — a continuous ECG monitoring wearable — were more likely to have their atrial fibrillation diagnosed early and receive subsequent preventive care, according to one-year results from a late-breaking study presented at the American College of Cardiology’s annual meeting.
The Apple Heart Study — which began enrollment at the end of November — has now begun data collection, with participants receiving prompts over the weekend to sign informed consent documents and initiate data collection.
The Scripps Translational Science Institute is working with Aetna and Johnson & Johnson to launch a trial that will test iRhythm's Zio Patch and the Amiigo activity tracker as possible new ways to screen at-risk populations for atrial fibrillation.
It's been almost a year since AliveCor began offering its first FDA-cleared algorithm, its atrial fibrillation detection algorithm, to customers.
AliveCor's AF detection algorithm
San Francisco-based AliveCor has received FDA clearance for two new algorithms for its smartphone-connected ECG: one that detects normality and one that detects interference.
Smartphone ECG company AliveCor announced the publication of a long-awaited independent trial of the technology conducted by the Cleveland Clinic.